BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33524787)

  • 1. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
    Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
    Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Roles of Purinergic Signaling in Diabetes.
    Fotino C; Dal Ben D; Adinolfi E
    Med Chem; 2018; 14(5):428-438. PubMed ID: 29485002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
    Dwyer KM; Kishore BK; Robson SC
    Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of purinergic signaling in diabetes: Focus on vascular function.
    Zhou R; Dang X; Sprague RS; Mustafa SJ; Zhou Z
    J Mol Cell Cardiol; 2020 Mar; 140():1-9. PubMed ID: 32057736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
    Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
    Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia alters E-NTPDases, ecto-5'-nucleotidase, and ectosolic and cytosolic adenosine deaminase activities and expression from encephala of adult zebrafish (Danio rerio).
    Capiotti KM; Siebel AM; Kist LW; Bogo MR; Bonan CD; Da Silva RS
    Purinergic Signal; 2016 Jun; 12(2):211-20. PubMed ID: 26769247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Watson D; Sluyter R
    Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1.
    Trueblood KE; Mohr S; Dubyak GR
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1213-23. PubMed ID: 21832250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.
    Fausther M; Lecka J; Soliman E; Kauffenstein G; Pelletier J; Sheung N; Dranoff JA; Sévigny J
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(4):G447-59. PubMed ID: 22135310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic signaling: a potential therapeutic target for ischemic stroke.
    Wang L; Li YJ; Yang X; Yang B; Zhang X; Zhang J; Zhang Q; Cheng XD; Wang JH; Yu NW
    Purinergic Signal; 2023 Mar; 19(1):173-183. PubMed ID: 36370253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of adenosine system at the onset of peritonitis.
    Nakav S; Naamani O; Chaimovitz C; Shaked G; Czeiger D; Zlotnik M; Douvdevani A
    Nephrol Dial Transplant; 2010 Mar; 25(3):931-9. PubMed ID: 19861313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfolding Role of a Danger Molecule Adenosine Signaling in Modulation of Microbial Infection and Host Cell Response.
    Lee JS; Yilmaz Ö
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29315226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical exercise prevents memory impairment in an animal model of hypertension through modulation of CD39 and CD73 activities and A2A receptor expression.
    Cardoso AM; Manfredi LH; Zanini D; Bagatini MD; Gutierres JM; Carvalho F; Tremblay A; Belló-Klein A; Rubin MA; Morsch VM; Sévigny J; Schetinger MRC
    J Hypertens; 2019 Jan; 37(1):135-143. PubMed ID: 30507864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine and adenosine receptors in colorectal cancer.
    Hajizadeh F; Masjedi A; Heydarzedeh Asl S; Karoon Kiani F; Peydaveisi M; Ghalamfarsa G; Jadidi-Niaragh F; Sevbitov A
    Int Immunopharmacol; 2020 Oct; 87():106853. PubMed ID: 32755765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectonucleotidases in Intestinal and Hepatic Inflammation.
    Vuerich M; Robson SC; Longhi MS
    Front Immunol; 2019; 10():507. PubMed ID: 30941139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adenosinergic system: a potential player in the pathogenesis of ANCA-associated vasculitis?
    Kling L; Krämer BK; Yard BA; Kälsch AI
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):143-151. PubMed ID: 29745882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.
    Bertelli R; Bodria M; Nobile M; Alloisio S; Barbieri R; Montobbio G; Patrone P; Ghiggeri GM
    Clin Exp Immunol; 2011 Oct; 166(1):55-63. PubMed ID: 21762125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromodulatory effect of the combination of metformin and vitamin D
    Pereira ADS; Miron VV; Castro MFV; Bottari NB; Assmann CE; Nauderer JN; Bissacotti BF; Mostardeiro VB; Stefanello N; Baldissarelli J; Palma TV; Morsch VMM; Schetinger MRC
    Mol Cell Endocrinol; 2023 Mar; 563():111852. PubMed ID: 36657632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
    Chiarella AM; Ryu YK; Manji GA; Rustgi AK
    Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.